Anika Therapeutics Reports 18% Revenue Growth in Fourth-Quarter 2009

BEDFORD, Mass.--(BUSINESS WIRE)--Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing, and repair, based on hyaluronic acid (“HA”) technology, today reported financial results for the quarter and year ended December 31, 2009.

MORE ON THIS TOPIC